Learning Objectives:

1. Recognize the shortcomings of commercial testing for inherited blood cancers

2. Understand a proper workup for inherited myeloid malignancy risk

3. Appreciate distinctive clinical outcomes for patients with inherited myeloid malignancies


Session date: 
06/23/2022 - 8:00am to 9:00am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Greg Roloff, MD